Medical Sciences
Research Agricultural
Total number of Record(s): 2413
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Anti-complement factor H (FH) associated hemolytic uremic syndrome (HUS) in children: Immunological and genetic basis, and functional characterization of autoantibodies | Dr. Aditi Sinha, Assistant Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Hemolytic uremic syndrome |
| Anti-complement factor H (FH) associated hemolytic uremic syndrome (HUS) in children: Immunological and genetic basis, and functional characterization of autoantibodies | Dr. Faruq Mohammed, Scientist, Institute of Genomics and Integrative Biology (IGIB), New Delhi | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Hemolytic uremic syndrome |
| A combinatorial study and evaluation of role of therapeutic agents/inhibitors on JAK/STAT pathway | Dr. Dil Afroze, Professor, Sher-e-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, Jammu and Kashmir | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Therapeutic agents/inhibitors on JAK/STAT pathway |
| Targeting telomerase transcriptionally and posttranscriptionally using small molecules and anti-telomerase peptides: Potential double blow to aggressive drug resistant cancers | Dr. Shantanu Chowdhury, Scientist, Institute of Genomics and Integrative Biology(IGIB), New Delhi | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Drug resistant cancer |
| Targeting telomerase transcriptionally and posttranscriptionally using small molecules and anti-telomerase peptides: Potential double blow to aggressive drug resistant cancers | Dr. Tushar Kanti Chakraborty, Professor, Department of Organic Chemistry, Indian Institute of Science (IISc), Bengaluru, Karnataka | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Drug resistant cancer |
| To understand the role of innate inflammatory mechanisms of macrophages in intestinal tuberculosis and Crohn's disease (Ver-2 of EMR/2016/000026) | Dr. Dhiraj Kumar, Scientist, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Intestinal tuberculosis and Crohn's disease |
| To understand the role of innate inflammatory mechanisms of macrophages in intestinal tuberculosis and Crohn's disease | Dr. Vineet Ahuja, Professor, Department of GastroEnterology, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Intestinal tuberculosis and Crohn's disease |
| Discovery of pyrimidines and intermediates as a human epidermal growth factor receptor (HER-2) and Apurinic/Apyrimidinic Endonuclease-1 (APE-1) inhibitors for breast cancer therapy: An synthetic approach | Dr. Guru Basavaraja Swamy, Associate Professor, Acharya Institute of Technology, Bengaluru, Karnataka | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | HER-2 and APE-1 inhibitors for breast cancer |
| A comparative in vitro evaluation of anti-bilious fruits of folklore fame in ameliorating obesity associated inflammation and insulin resistance | Dr. Premalatha Shetty, Sri Dharmasthala Manjunatheshwara College of Ayurveda & Hospitals, Udupi, Karnataka | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Anti-bilious fruits for obesity and insulin resistance |
| Identification of genetic mutations and risk factors associated with the conferring of extensive drugs resistance (XDR) in Indian isolates of Mycobacterium tuberculosis | Dr. Ajay Vir Singh, Scientist, National Jalma Institute of Leprosy and Other Mycobacterial Diseases, Agra, Uttar Pradesh | 2017 | Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India | Mycobacterium tuberculosis |